Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan

Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan

US Patent 9259406 · Granted Feb 16, 2016

Estimated economic value: $23,382,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antitumors combinations containing antibodies recognizing specifically CD38 and 2016
Antitumor combinations containing antibodies recognizing specifically CD38 and v2014
Antitumor combinations containing antibodies recognizing specifically CD38 and v2014
Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivativ2013
Combination comprising combretastatin and anticancer agents2010
Use of a taxoid to treat abnormal cell proliferation in the brain2002
Compositions containing at least one farnesyl transferase inhibitor and at least2002